ELABORATION OF GUIDELINE FOR MONITORING IN RELATIVE BIOAVAILABILITY / PHARMACEUTICAL BIOEQUIVALENCE STUDY BY THE SPONSOR

Autores

  • Paula Thais Gozzi
  • Fernanda Giacomini Bueno
  • Patrícia Moura da Rosa Zimmermann
  • Liberato Brum Junior

DOI:

https://doi.org/10.25110/arqsaude.v26i3.2022.8400

Resumo

For registration of generic and similar drugs, it is necessary to carry out pharmaceutical equivalence (PE) tests and pharmaceutical bioequivalence (PB). To carry out these tests, duly qualified research centers are contracted, which need to be monitored by the sponsor who is legally responsible for the activities. To this end, it is the recommendation of the Document of the Americas, periodic monitoring to verify compliance with quality requirements, Standard Operating Procedures, Good Clinical Practices (GCP), Good Laboratory Practices (GLP), of the applicable regulatory framework, as well as of compliance with the study protocol. Thus, monitoring is a methodical and documented process to evaluate the degree of adhesion of the center to the planned design for the evaluation of the formulations. To this end, the implementation of a standardized and easily completed guideline is a very important tool to guarantee a consistent evaluation and maintain the organizational memory of the evaluated items by monitors designated by the sponsor, contributing to the constant improvement of the contracted centers and supporting traceability of the studies. This work provided a systemic view of the evidence process related mainly to pharmaceutical bioequivalence, with the monitoring guideline summarizing the items of greatest relevance to be verified.

Downloads

Publicado

27-09-2022

Como Citar

GOZZI, Paula Thais; BUENO, Fernanda Giacomini; ZIMMERMANN, Patrícia Moura da Rosa; JUNIOR, Liberato Brum. ELABORATION OF GUIDELINE FOR MONITORING IN RELATIVE BIOAVAILABILITY / PHARMACEUTICAL BIOEQUIVALENCE STUDY BY THE SPONSOR. Arquivos de Ciências da Saúde da UNIPAR, [S. l.], v. 26, n. 3, 2022. DOI: 10.25110/arqsaude.v26i3.2022.8400. Disponível em: https://revistas.unipar.br/index.php/saude/article/view/8400. Acesso em: 4 nov. 2024.

Edição

Seção

Artigos